It’s a great idea to invest in us – and here’s why
Related NewsView All News
MilliporeSigma today announced that Combined Therapeutics Inc., Cambridge, Massachusetts, has been selected as the North American winner of its 2020 Advance Biotech Grant Program
Merck KGaA, Darmstadt, Germany today announced that Dr. Luciano Rossetti, MD, will be retiring as Global Head of Research & Development (R&D) for the Healthcare business sector.
MilliporeSigma has bolstered its viral vector manufacturing capabilities with the launch of its VirusExpress™ Lentiviral Production Platform
Share PriceCheck Share Price
Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.
Our Financial Reporting Center offers you the opportunity to select from financial data on an annual or quarterly basis.